-+ 0.00%
-+ 0.00%
-+ 0.00%

Tenaya Therapeutics Approves Restructuring Plan; Restructuring Plan To Reduce Cash Expenses; Restructuring Plan To Extend Cash Runway Into H2 2026; To Reduce Workforce Under Restructuring Plan; To Incur $1.6M-$2.7M In Restructuring Charges; Expects To Recognize Charges By Q3 2025

Benzinga·03/28/2025 20:44:10
Listen to the news

- SEC Filing